Spacer Image Alafevir EM (Emtricitabine & Tenofovir Alafenamide 200mg / 25mg) 30 Tablets Alafevir EM

Spacer Image Alafevir EM (Emtricitabine & Tenofovir Alafenamide 200mg / 25mg) 30 Tablets Alafevir EM About

Alafevir EM tablets are a fixed dose combination antiretroviral treatment for Human Immunodeficiency Virus (HIV) infection in adults and adolescents aged 12 years and older, with body weight at least 35 kg. Alafevir EM tablets are used in combination with other medications that have a different mechanism of action to the components in Alafevir EM, and can be used for patients who have already received treatment with other medications for HIV, or as first line therapy for treatment-inexperienced patients. However, Alafevir EM tablets should not be used for patients who have a history of treatment failure with other antiretroviral medications, or who have known mutations associated with resistance to the individual components in Alafevir EM tablets. HIV impairs the immune system by attacking specific immune cells called CD4⁺ cells that are involved in fighting infection and this can lead to opportunistic, life-threatening infection (infections that would not normally be harmful); also if too many CD4⁺ cells are destroyed this can result in acquired immune deficiency syndrome (AIDS). Alafevir EM tablets prevent or slow down the ability of HIV to replicate and spread, which keeps the amount of virus in the blood (viral load) down to a low level and this results in an increase in CD4⁺ cell numbers, so that the immune system can recover, reducing the risk of disease progression.